Can psychological factors help us to determine adherence to CPAP? A prospective study

European Respiratory Journal

Volumn 24, Issue 3, 2004, Pages 461-465

  Wild, M R ^a   Engleman, H M ^b   Douglas, N J ^b   Espie, C A ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Patient compliance; Positive pressure ventilation; Sleep apnoea syndromes

Indexed keywords

ADULT; ARTICLE; BODY MASS; COGNITION; CONTROLLED STUDY; EXPERIMENTAL MODEL; FEMALE; FOLLOW UP; HEALTH STATUS; HUMAN; HYPOTHESIS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH; PATIENT ATTITUDE; PATIENT COMPLIANCE; POSITIVE END EXPIRATORY PRESSURE; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT; RISK ASSESSMENT; SCORING SYSTEM; SELF CONCEPT; SLEEP APNEA SYNDROME; SOCIAL ASPECT; TIME; TREATMENT WITHDRAWAL; VARIANCE;

CONTINUOUS POSITIVE AIRWAY PRESSURE; FEMALE; HUMANS; INTERNAL-EXTERNAL CONTROL; LOGISTIC MODELS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PROSPECTIVE STUDIES; QUESTIONNAIRES; SELF EFFICACY; SLEEP APNEA, OBSTRUCTIVE;

EID: 4544321147     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.04.00114603     Document Type: Article

References (36)

1. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Bader S. The occurrence of sleep-disordered breathing among middle-aged adults. New Engl J Med 1993; 328: 1230-1235.
2. Kribbs NB, Pack AI, Kline LR, et al. Objective measurement of patterns of nasal CPAP use by patients with obstructive sleep apnea. Am Rev Respir Dis 1993; 147: 887-895.
3. Douglas NJ. Systematic review of the efficacy of CPAP. Thorax 1998; 53: 414-415.
4. Engleman HM, Kingshott RN, Wraith PK, Mackay TW, Deary IJ, Douglas NJ. Randomized placebo-controlled crossover trial of CPAP for mild sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med 1999; 159: 461-467.
5. Jenkinson C, Davies RJ, Mullins R, Stradling JR. Comparison of therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised prospective parallel trial. Lancet 1999; 353: 2100-2105.
6. George CF, Nickerson PW, Hanly PJ, Miller TW, Kryger MH. Sleep apnea patients have more automobile accidents. Lancet 1987; 2: 447.
7. Krieger J, Meslier N, Lebrun T, et al. Accidents in obstructive sleep apnea patients treated with nasal continuous positive airway pressure; a prospective study. Chest 1997; 112: 1561-1566.
8. Faccenda JF, Mackay TW, Boon NA, Douglas NJ. Randomized placebo-controlled trial of continuous positive airway pressure on blood pressure in the sleep apnea-hypopnea syndrome. Am J Respir Crit Care Med 2001; 163: 344-348.
9. Pepperell JC, Ramdassingh-Dow S, Crosthwaite N, et al. Ambulatory blood pressure after therapeutic and sub-therapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. Lancet 2002; 359: 204-210.
10. Engleman HM, Wild MR. Improving CPAP use by patients with the sleep apnoea/hypopnoea syndrome (SAHS). Sleep Medicine Reviews 2003; 7: 81-99.
11. Hoffstein V, Viner S, Mateika A, Conway J. Treatment of obstructive sleep apnea with nasal continuous positive airway pressure: patient compliance, perception of benefits, and side effects. Am Rev Respir Dis 1992; 145: 841-845.
12. Meurice J, Dore P, Paquereau J, et al. Predictive factors of long-term compliance with nasal continuous positive airway pressure treatment in sleep apnea syndrome. Chest 1994; 105: 429-433.
13. Rauscher H, Popp W, Wanke T, Zwick H. Acceptance of CPAP therapy for sleep apnea. Chest 1991; 100: 1019-1023.
14. Reeves-Hoche MK, Meck R, Zwillich CW. Nasal CPAP: an objective evaluation of patient compliance. Am J Respir Crit Care Med 1994; 149: 149-154.
15. McArdle N, Devereux G, Heidarnejad H, Engleman HM, Mackay TM, Douglas NJ. Long-term use of CPAP therapy for sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med 1999; 159: 1108-1114.
16. Engleman HM, Martin SE, Douglas NJ. Compliance with CPAP therapy in patients with sleep apnoea/hypopnoea syndrome. Thorax 1994; 49: 263-266.
17. Rauscher H, Formanek D, Popp W, Zwick H. Self-reported vs measured compliance with nasal CPAP for obstructive sleep apnea. Chest 1993; 103: 1675-1680.
18. Fletcher EC, Luckett RA. The effects of positive reinforcement on hourly compliance in nasal continuous positive airway pressure users with obstructive sleep apnea. Am Rev Respir Dis 1991; 143: 936-941.
19. Conner M, Norman P. Health behaviour. In: Bellack AS, Hersen M, eds. Comprehensive Clinical Psychology. Johnson DW, Johnson M, eds., New York, Pergamon. Health Psychology 1998; Vol. 8, pp. 1-37.
20. Marteau TM. Health beliefs and attributions. In: Broome AK, ed. Health psychology: processes and applications. London, Chapman Hall, 1995; pp. 1-23.
21. Tillotson LM, Smith MS. Locus of control, social support, and adherence to the diabetic regimen. Diabetes Educ 1996; 22: 133-139.
22. Edinger JD, Carwile S, Miller P, Hope V, Mayti C. Psychological status, syndromatic measures, and compliance with nasal CPAP therapy for sleep apnea. Percept Mot Skills 1994; 78: 1116-1118.
23. Hoy CJ, Vennelle M, Kingshott RN, Engleman HM, Douglas NJ. Can intensive support improve continuous positive airway pressure use in patients with sleep apnea/hypopnea syndrome? Am J Respir Crit Care Med 1999; 59: 1096-1100.
24. Stepnowski CJ, Marler MR, Ancoli-Israel S. Determinants of nasal CPAP compliance. Sleep Medicine 2002; 3: 239-247.
25. Stepnowski CJ, Bardwell WA, Moore PJ, Ancoli-Israel S, Dimsdale JE. Psychologic correlates of compliance with continuous positive airway pressure. Sleep 2002; 7: 758-762.
26. Wallston KA. Hocus-pocus, the focus isn't strictly on the locus: Rotter's social learning theory modified for health. Cog Ther Res 1992; 16: 251-252.
27. Wallston KA, Wallston BA, De Vellis R. Development of the multidimensional health locus of control (MHLC) scales. Health Educ Monogr 1978; 6: 161-170.
28. Lau RR, Hartman KA, Ware JE. Health as a value: methodological and theoretical considerations. Health Psychol 1986; 5: 25-43.
29. Schwarzer R, ed. Self-efficacy: thought control of action. Washington DC, Hemisphere, 1992.
30. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991; 14: 540-545.
31. Hosmer D, Lemeshow S. Model building strategies and methods for logistic regression. In: Applied logistic regression. New York, Wiley, 1989; pp. 91-142.
32. Kavanagh DJ, Gooley S, Wilson PH. Prediction of adherence and control in diabetes. J Behav Med 1993; 16: 509-522.
33. Weaver TE, Maislin G, Dinges DF, et al. Self-efficacy in sleep apnea: instrument development and patient perceptions of obstructive sleep apnea risk, treatment benefit, and volition to use continuous positive airway pressure. Sleep 2003; 26: 727-732.
34. Lutfey KE, Wishner WJ. Beyond 'compliance' is 'adherence'. Improving the prospect of diabetes care. Diabetes Care 1999; 22: 635-639.
35. Vermeire E, Hearnshaw H, Van Royen P, Denekens J. Patient adherence to treatment: three decades of research. A comprehensive review. J Clin Pharm Ther 2001; 26: 331-342.
36. Likar LL, Panciera TM, Erickson AD, Rounds S. Group education sessions and compliance with nasal CPAP therapy. Chest 1997; 111: 1273-1277.